her2 target new treatment metastatic breast cancer using humanized monoclonal antibody mab trastuzumb herceptin novel emitting construct targeting her2 extracellular domain breast cancer cells produced chelation characterized vitro study used western blot flow cytometry analysis examine expression her2 panel established human metastatic breast cancer cell lines inner salt mts assay evaluate cytotoxicity tunel assay analyze cellular apoptosis results demonstrate human breast cancer cell lines express high levels her2 protein expresses low levels her2 alpha conjugate ac specifically cytotoxic cell lines her2 fashion resulting cellular death apoptosis results suggest ac novel agent treatment breast cancer cell clusters high levels her2 expression alpha particle 213bi herceptin NUMBER NUMBER dimethylthiazol NUMBER yl NUMBER NUMBER carboxymethoxyphenyl NUMBER NUMBER sulfophenyl 2h tetrazolium bt NUMBER sk br NUMBER mda NUMBER 213bi herceptin level dependent 231bi herceptin micro metastases